Silo Pharma, Inc.
SILO
$0.6283
-$0.0108-1.69%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -29.24% | -28.65% | -54.35% | -40.68% | 8.02% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,169.23% | -1,350.00% | -100.00% | -100.00% | -97.03% |
| Change in Net Operating Assets | -150.28% | -1,577.69% | 461.79% | 4.43% | -52.61% |
| Cash from Operations | -75.64% | -95.69% | -0.81% | -25.63% | -33.05% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -59.33% | 792.83% | -100.85% | -103.21% | 124.94% |
| Cash from Investing | -59.33% | 792.83% | -100.85% | -103.21% | 124.94% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 25.15% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | 100.00% | 100.00% | 55.95% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 29.61% | -- | 100.00% | 1,295.26% | 1,333.28% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -34.89% | 10.18% | -128.73% | 764.88% | 140.78% |